AAAAAA
Results: 1-25/93
Authors:
Fruchart, JC
Citation: Jc. Fruchart, Introducing a novel targeted approach to the treatment of hypercholesterolaemia: focus on the exogenous pathway - Proceedings of a satellite symposium held during the XXII Congress of the European Society of Cardiology, Amsterdam, The Netherlands, 26 August 2000 - Foreword, EUR H J SUP, 3(E), 2001, pp. E1-E1
Authors:
Fruchart, JC
Leitersdorf, E
Shepherd, J
Catapano, AL
Stein, E
Citation: Jc. Fruchart et al., Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement - Discussion, EUR H J SUP, 3(E), 2001, pp. E24-E25
Authors:
Delerive, P
Monte, D
Dubois, G
Trottein, F
Fruchart-Najib, J
Mariani, J
Fruchart, JC
Staels, B
Citation: P. Delerive et al., The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response, EMBO REP, 2(1), 2001, pp. 42-48
Authors:
Fruchart, JC
Citation: Jc. Fruchart, PPAR and cardiovascular risk, J CARD RISK, 8(4), 2001, pp. 185-186
Authors:
Duez, H
Fruchart, JC
Staels, B
Citation: H. Duez et al., PPARs in inflammation, atherosclerosis and thrombosis, J CARD RISK, 8(4), 2001, pp. 187-194
Authors:
Asset, G
Bauge, E
Fruchart, JC
Dallongeville, J
Citation: G. Asset et al., Lack of triglyceride-lowering properties of fish oil in apolipoprotein E-deficient mice, ART THROM V, 21(3), 2001, pp. 401-406
Authors:
Bard, JM
Charles, MA
Juhan-Vague, I
Vague, P
Andre, P
Safar, R
Fruchart, JC
Eschwege, E
Citation: Jm. Bard et al., Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity - The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study, ART THROM V, 21(3), 2001, pp. 407-414
Authors:
Chinetti, G
Lestavel, S
Bocher, V
Remaley, AT
Neve, B
Torra, IP
Teissier, E
Minnich, A
Jaye, M
Duverger, N
Brewer, HB
Fruchart, JC
Clavey, V
Staels, B
Citation: G. Chinetti et al., PPAR-alpha and PPAR-gamma activators induce cholesterol removal from humanmacrophage foam cells through stimulation of the ABCA1 pathway, NAT MED, 7(1), 2001, pp. 53-58
Authors:
Fruchart, JC
Staels, B
Duriez, P
Citation: Jc. Fruchart et al., PPARs, metabolic disease and atherosclerosis, PHARMAC RES, 44(5), 2001, pp. 345-352
Authors:
Torra, IP
Chinetti, G
Duval, C
Fruchart, JC
Staels, B
Citation: Ip. Torra et al., Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice, CURR OP LIP, 12(3), 2001, pp. 245-254
Authors:
Lestavel, S
Chinetti, G
Bocher, V
Fruchart, JC
Clavey, V
Staels, B
Citation: S. Lestavel et al., Peroxisome proliferator-activated receptors in human atherosclerosis, M S-MED SCI, 17(5), 2001, pp. 637-642
Authors:
Dallongeville, J
Meirhaeghe, A
Cottel, D
Fruchart, JC
Amouyel, P
Helbecque, N
Citation: J. Dallongeville et al., Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans, INT J OBES, 25(7), 2001, pp. 1012-1017
Authors:
Boullier, A
Hennuyer, N
Tailleux, A
Furman, C
Duverger, N
Caillaud, JM
Castro, G
Fievet, C
Fruchart, JC
Duriez, P
Citation: A. Boullier et al., Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia, CLIN SCI, 100(3), 2001, pp. 343-355
Authors:
Pennacchio, LA
Olivier, M
Hubacek, JA
Cohen, JC
Cox, DR
Fruchart, JC
Krauss, RM
Rubin, EM
Citation: La. Pennacchio et al., An apolipoprotein influencing triglycerides in humans and mice revealed bycomparative sequencing, SCIENCE, 294(5540), 2001, pp. 169-173
Authors:
Kandoussi, AM
Glowacki, F
Duriez, P
Tacquet, A
Fruchart, JC
Noel, C
Citation: Am. Kandoussi et al., Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients, NEPHRON, 89(3), 2001, pp. 303-308
Authors:
Quilliot, D
Walters, E
Guerci, B
Fruchart, JC
Duriez, P
Drouin, P
Ziegler, O
Citation: D. Quilliot et al., Effect of the inflammation, chronic hyperglycemia, or malabsorption on theapolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis, METABOLISM, 50(9), 2001, pp. 1019-1024
Authors:
Delerive, P
Fruchart, JC
Staels, B
Citation: P. Delerive et al., Peroxisome proliferator-activated receptors in inflammation control, J ENDOCR, 169(3), 2001, pp. 453-459
Authors:
Martin, G
Duez, H
Blanquart, C
Berezowski, V
Poulain, P
Fruchart, JC
Najib-Fruchart, J
Glineur, C
Staels, B
Citation: G. Martin et al., Statin-induced inhibition of the Rho-signaling pathway activates PPAR alpha and induces HDL apoA-I, J CLIN INV, 107(11), 2001, pp. 1423-1432
Authors:
Dallongeville, J
Bauge, E
Tailleux, A
Peters, JM
Gonzalez, FJ
Fruchart, JC
Staels, B
Citation: J. Dallongeville et al., Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil, J BIOL CHEM, 276(7), 2001, pp. 4634-4639
Authors:
Raspe, E
Duez, H
Gervois, P
Fievet, C
Fruchart, JC
Besnard, S
Mariani, J
Tedgui, A
Staels, B
Citation: E. Raspe et al., Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha, J BIOL CHEM, 276(4), 2001, pp. 2865-2871
Authors:
Gervois, P
Vu-Dac, N
Kleemann, R
Kockx, M
Dubois, G
Laine, B
Kosykh, V
Fruchart, JC
Kooistra, T
Staels, B
Citation: P. Gervois et al., Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta, J BIOL CHEM, 276(36), 2001, pp. 33471-33477
Authors:
Bouly, M
Masson, D
Gross, B
Jiang, XC
Fievet, C
Castro, G
Tall, AR
Fruchart, JC
Staels, B
Lagrost, L
Luc, G
Citation: M. Bouly et al., Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate, J BIOL CHEM, 276(28), 2001, pp. 25841-25847
Authors:
Baroukh, N
Ostos, MA
Vergnes, L
Recalde, D
Staels, B
Fruchart, JC
Ochoa, A
Castro, G
Zakin, MM
Citation: N. Baroukh et al., Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet, FEBS LETTER, 502(1-2), 2001, pp. 16-20
Authors:
Neve, BP
Corseaux, D
Chinetti, G
Zawadzki, C
Fruchart, JC
Duriez, P
Staels, B
Jude, B
Citation: Bp. Neve et al., PPAR alpha agonists inhibit tissue factor expression in human monocytes and macrophages, CIRCULATION, 103(2), 2001, pp. 207-212
Authors:
Junquero, D
Pilon, A
Carilla-Durand, E
Patoiseau, JF
Tarayre, JP
Torpier, G
Staels, B
Fruchart, JC
Colpaert, FC
Clavey, V
Delhon, A
Citation: D. Junquero et al., Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture, BIOCH PHARM, 61(4), 2001, pp. 387-398